Ogata, H., Aoyama, N., Mizushima, S., Hagino, A., & Hibi, T. (2017). Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: A randomized, double-blind study. Intest Res.
Citação norma ChicagoOgata, Haruhiko, Nobuo Aoyama, Seiichi Mizushima, Atsushi Hagino, and Toshifumi Hibi. "Comparison of Efficacy of Multimatrix Mesalazine 4.8 G/day Once-daily With Other High-dose Mesalazine in Active Ulcerative Colitis: A Randomized, Double-blind Study." Intest Res 2017.
Citação norma MLAOgata, Haruhiko, et al. "Comparison of Efficacy of Multimatrix Mesalazine 4.8 G/day Once-daily With Other High-dose Mesalazine in Active Ulcerative Colitis: A Randomized, Double-blind Study." Intest Res 2017.